RJA
ARAV

Raymond James & Associates’s Aravive, Inc. Common Stock ARAV Stock Holding History

Raymond James & Associates’s Portfolio ARAV Stock Details ARAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,205
Closed -$77K – 3549
2017
Q3 		$77K Buy
+5,205
New +$525K ﹤0.01% 3208

Other funds holding ARAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Raymond James & Associates's ARAV Position: Q4 2017 in Review

Raymond James & Associates sold out of Aravive, Inc. Common Stock (ARAV) in Q4 2017, closing a stake of 5,205 shares — an estimated $77K sold.

Raymond James & Associates first reported a position in ARAV in Q3 2017 and held it in 1 quarter. The position peaked at $77K in Q3 2017. 85 funds tracked by Wall St. Rank hold ARAV as of Q4 2017.

  • Raymond James & Associates reported no remaining Aravive, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Raymond James & Associates sold 5,205 Aravive, Inc. Common Stock shares in Q4 2017, an estimated $77K.
  • Raymond James & Associates first reported a position in Aravive, Inc. Common Stock in Q3 2017 and held it in 1 quarter.
  • Raymond James & Associates's Aravive, Inc. Common Stock position peaked at $77K in Q3 2017.
  • 85 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q4 2017.

Based on Raymond James & Associates's 13F filing for Q4 2017, filed 14 Feb 2018.